- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Defence Therapeutics Inc (DTC)
Defence Therapeutics Inc stock price live, this page displays NLB DTC stock exchange data. View the DTC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Defence Therapeutics Inc real time stock price chart below.
What Is the Defence Therapeutics Inc Stock Price Today?
The Defence Therapeutics Inc stock price today is 0.59.
What Is the Stock Symbol for Defence Therapeutics Inc?
The stock symbol for Defence Therapeutics Inc is ""DTC.""
What Stock Exchange Does Defence Therapeutics Inc Trade On?
Defence Therapeutics Inc is listed and trades on the CBOE Canada stock exchange.
Is Defence Therapeutics Inc a Good Stock to Buy?
Determining whether Defence Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DTC quote. (ISIN: CA24463V1013)
What Is the Defence Therapeutics Inc Stock Price Today?
The Defence Therapeutics Inc stock price today is 0.59.
What Is the Stock Symbol for Defence Therapeutics Inc?
The stock symbol for Defence Therapeutics Inc is ""DTC.""
What Stock Exchange Does Defence Therapeutics Inc Trade On?
Defence Therapeutics Inc is listed and trades on the CBOE Canada stock exchange.
Is Defence Therapeutics Inc a Good Stock to Buy?
Determining whether Defence Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DTC quote. (ISIN: CA24463V1013)
0.59
+0.04(+7.27%)
Closed·
Fair Value
An estimate of a Defence Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.58
0.60
52 wk Range
0.48
1.60
DTC Scorecard
Full Analysis
Suffers from weak gross profit margins
DTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Defence Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.580.60
52 wk Range
0.481.60
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
DTC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Defence Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Short term obligations exceed liquid assets
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Defence Therapeutics Inc Company Profile
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology, including antibody drug conjugates targeting various cancers; anti-cancer AccuTOX program, which has completed preclinical studies for solid T-cell lymphoma, breast cancer, and melanoma; ARM-X vaccine program, a mesenchymal stem cell-based vaccine targeting cancer; and mRNA vaccination program. It also offers Accuvac for dendritic cell cancer vaccines; a protein-based vaccine formulation against COVID and infectious diseases; and cervical cancer vaccine. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.
Compare DTC to Peers and Sector
Metrics to compare | DTC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDTCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.7x | −3.5x | −0.5x | |
PEG Ratio | −0.12 | 0.01 | 0.00 | |
Price/Book | −146.9x | 1.1x | 2.6x | |
Price / LTM Sales | - | 1.9x | 3.3x | |
Upside (Analyst Target) | - | 258.8% | 42.8% | |
Fair Value Upside | Unlock | −2.3% | 6.5% | Unlock |
Earnings
Latest Release
May 23, 2025
EPS / Forecast
-0.02 / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Defence Therapeutics Trade On?
Defence Therapeutics is listed and trades on the CBOE Canada Exchange stock exchange.
What Is the Stock Symbol for Defence Therapeutics?
The stock symbol for Defence Therapeutics is "DTC."
What Is the Defence Therapeutics Market Cap?
As of today, Defence Therapeutics market cap is 32.84M.
What Is Defence Therapeutics's Earnings Per Share (TTM)?
The Defence Therapeutics EPS (TTM) is -0.08.
From a Technical Analysis Perspective, Is DTC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Defence Therapeutics Stock Split?
Defence Therapeutics has split 0 times.
How Many Employees Does Defence Therapeutics Have?
Defence Therapeutics has 0 employees.
What is the current trading status of Defence Therapeutics (DTC)?
As of 06 Aug 2025, Defence Therapeutics (DTC) is trading at a price of 0.59, with a previous close of 0.59. The stock has fluctuated within a day range of 0.58 to 0.60, while its 52-week range spans from 0.48 to 1.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.